According to MarketsandMarkets™, The global Digital Pathology Market is projected to grow from USD 1.58 billion in 2026 to USD 2.86 billion by 2031, at a CAGR of 12.5% during the forecast period. This growth is primarily driven by the ongoing transition from traditional microscope-based workflows to fully digital pathology systems, enabling faster, more accurate, and scalable diagnostic processes.
Browse 310 market data Tables and 50 Figures spread through 283 Pages and in-depth TOC on “Digital Pathology Market
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=844
Healthcare providers and diagnostic laboratories are increasingly adopting whole slide imaging technologies, which allow tissue samples to be digitized, stored, and shared efficiently. This shift is significantly improving collaboration, workflow efficiency, and diagnostic accuracy across healthcare systems.
The growing integration of artificial intelligence (AI) and machine learning into digital pathology platforms is further accelerating market growth. These technologies assist pathologists in detecting abnormalities, improving cancer diagnosis accuracy, and reducing manual workloads. AI-driven tools are also playing a critical role in drug discovery and biomarker identification, enhancing the value of digital pathology for pharmaceutical and biotechnology companies.
Additionally, the increasing adoption of cloud-based platforms is enabling seamless storage and remote access to large pathology datasets. Strategic collaborations—such as the partnership between Roche and PathAI to develop AI-enabled companion diagnostics—highlight the industry’s focus on advancing digital and AI-powered pathology solutions.
Veterinary Pathology Segment to Register Highest Growth
By type, the veterinary pathology segment is expected to witness the fastest growth during the forecast period. This growth is driven by the increasing adoption of digital pathology in veterinary diagnostics, preclinical research, and toxicologic studies.
Rising healthcare expenditure for companion animals and growing demand for advanced diagnostic solutions are supporting the adoption of digital technologies in veterinary laboratories. Additionally, increasing R&D activities and the expanding role of contract research organizations (CROs) in animal-based studies are contributing to segment growth.
Oncology Segment Leads Market Demand
By indication, the oncology segment held the largest share of the digital pathology market in 2025. The growing adoption of precision medicine and personalized cancer therapies has significantly increased the demand for digital pathology solutions in oncology.
Digital pathology is widely used for companion diagnostics, biomarker discovery, clinical trials, and treatment monitoring. The increasing use of computational pathology is enabling faster and more consistent cancer detection and quantification. Moreover, the widespread adoption of digital pathology by life sciences companies for drug development highlights its expanding role beyond traditional diagnostics.
Speak To Analyst:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=844
Asia Pacific Emerges as Fastest-Growing Region
The Asia Pacific region is expected to register the highest growth during the forecast period. This growth is driven by improving healthcare infrastructure, rising disposable incomes, and increasing demand for advanced diagnostic technologies.
Government initiatives supporting healthcare modernization, such as China’s Healthy China 2030 plan, and rising healthcare investments in countries like India and Southeast Asia are accelerating the adoption of digital pathology solutions. With a large and growing population, the region presents significant opportunities for market expansion.
Competitive Landscape
The digital pathology market is highly competitive, with key players focusing on AI integration, cloud capabilities, and strategic collaborations. Prominent companies include: Prominent players in the digital pathology market include Huron Digital Pathology (Canada), Hologic, Inc. (US), Corista (US), Indica Labs Inc. (US), 3DHISTECH (Hungary), Objective Pathology Services Limited (Canada), OptraSCAN (US), Sectra AB (Sweden), Akoya Biosciences, Inc. (US), Hamamatsu Photonics K.K. (Japan), F. Hoffmann-La Roche Ltd. (Switzerland), Apollo Enterprise Imaging (US), XIFIN, Inc. (US), Proscia Inc. (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Fujifilm Holdings Corporation (Japan), Danaher Corporation (US), Koninklijke Philips N.V. (Netherlands), Mikroscan Technologies, Inc. (US), PathAI (US), Motic Digital Pathology (US), and Kanteron Systems (Spain).
These companies are investing heavily in AI-driven diagnostic tools, scalable cloud platforms, and integrated solutions to enhance diagnostic accuracy and workflow efficiency.
Related Reports:
Tissue Diagnostics Market – Global Forecast to 2030
Drug Discovery Services Market – Global Forecast to 2030
Media ContactCompany Name: MarketsandMarkets™ Research Private Ltd.Contact Person: Mr. Rohan SalgarkarEmail: Send EmailPhone: 18886006441Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445City: FloridaState: FloridaCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/digital-pathology-market-844.html
